Evidence map›Paper›PMID 42315502›Full record

ArticleBlood cancer journal2026

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

John Sharp, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Lindsey Fitzgerald, Daniel Reef, Andinet Teferra, Timothy J Voorhees, Supriya Gupta and 4 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

John SharpJames Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-5765-8549
Subodh BhattaJames Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-3804-5370
Jennifer J HuangFred Hutchinson Cancer Center, University of Washington , Seattle, WA, USA.ORCID http://orcid.org/0000-0003-0863-9389
Colin J ThomasAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Omar ElghawyAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Lindsey FitzgeraldHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Daniel ReefLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-2804-0584
Andinet TeferraMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Timothy J VoorheesJames Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-7603-6454
Supriya GuptaMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0001-5144-3467
Natalie S GroverLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-1346-3157
Stefan K BartaAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-3280-5271
Mazyar ShadmanFred Hutchinson Cancer Center, University of Washington , Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3365-6562
Narendranath EpperlaJames Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, USA. naren.epperla@hci.utah.edu.ORCID http://orcid.org/0000-0002-8216-3457

Funding

Training Hematology and Oncology Fellows in Clinical ResearchT32CA247815 · NCI · OHIO STATE UNIVERSITY · PI VERSCHRAEGEN, CLAIRE F., WESOLOWSKI, ROBERT · 2020 to 2024
$862k
U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32CA247815
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42315502
PMCPMC13279774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.